[25-NSE] Streamline Health Solutions, Inc. SEC Filing
Streamline Health Solutions, Inc. submitted a Form 25 notifying removal of its common stock from listing and/or registration on the Nasdaq Stock Market LLC. The filing lists the issuer's principal office and telephone number, cites Nasdaq's statement that it complied with applicable rules to file Form 25, and is signed by Jennifer Fainer, CDO Analyst, dated 2025-08-12.
Streamline Health Solutions, Inc. ha presentato un Form 25 notificando la rimozione delle sue azioni ordinarie dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. La comunicazione indica la sede principale e il numero di telefono dell'emittente, cita la dichiarazione di Nasdaq secondo cui ha rispettato le norme applicabili nel depositare il Form 25, ed è firmata da Jennifer Fainer, Analista CDO, in data 2025-08-12.
Streamline Health Solutions, Inc. presentó un Form 25 notificando la eliminación de sus acciones ordinarias de la cotización y/o registro en el Nasdaq Stock Market LLC. La presentación indica la oficina principal y el número de teléfono del emisor, cita la declaración de Nasdaq de que cumplió las normas aplicables al presentar el Form 25, y está firmada por Jennifer Fainer, Analista CDO, con fecha 2025-08-12.
Streamline Health Solutions, Inc.는 보통주를 Nasdaq Stock Market LLC의 상장 및/또는 등록에서 제외한다는 통지를 위해 Form 25를 제출했습니다. 제출 서류에는 발행인의 본사 주소와 전화번호가 기재되어 있고, Form 25를 제출하는 데 있어 적용 규정을 준수했다는 Nasdaq의 진술을 인용하고 있으며, Jennifer Fainer, CDO 분석가의 서명이 있으며 날짜는 2025-08-12입니다.
Streamline Health Solutions, Inc. a déposé un Form 25 notifiant le retrait de ses actions ordinaires de la cotation et/ou de l'enregistrement sur le Nasdaq Stock Market LLC. Le dossier indique le siège social et le numéro de téléphone de l'émetteur, cite la déclaration de Nasdaq selon laquelle elle a respecté les règles applicables lors du dépôt du Form 25, et est signé par Jennifer Fainer, analyste CDO, en date du 2025-08-12.
Streamline Health Solutions, Inc. hat ein Form 25 eingereicht, das die Entfernung seiner Stammaktien von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC anzeigt. Die Einreichung nennt die Hauptniederlassung und Telefonnummer des Emittenten, zitiert die Erklärung der Nasdaq, dass sie die anwendbaren Regeln bei der Einreichung des Form 25 eingehalten hat, und ist von Jennifer Fainer, CDO-Analystin, unterzeichnet, datiert 2025-08-12.
- Exchange certification of compliance is explicitly stated, indicating procedural steps were followed to file Form 25.
- Filing includes clear identification of issuer, security class (common stock), exchange, and a dated signature from an exchange representative.
- Notice of removal: the Form 25 notifies that the company's common stock will be struck from Nasdaq listing and/or registration.
- Ambiguity on basis for removal: the document text does not show which specific rule provision checkbox was designated, so the filing does not clarify whether the withdrawal is voluntary or otherwise.
Insights
TL;DR: Form 25 notifies Nasdaq will remove STRM common stock from listing; the exchange certifies procedural compliance; filing signed Aug 12, 2025.
The Form 25 is a formal notification that the Nasdaq has initiated the process to strike Streamline Health Solutions, Inc.'s common stock from listing and/or registration. The filing plainly identifies the issuer, the security class as common stock, and the exchange. Nasdaq certifies it complied with the rules to file this notice. The document is dated and signed by an exchange representative, establishing administrative record of the removal action.
TL;DR: Regulatory filing documents removal action and exchange compliance; signature included, but the filing does not clarify which specific rule checkbox was designated.
The submission includes explicit statements that Nasdaq has "complied with its rules to strike the class of securities from listing and/or withdraw registration" and also references the issuer-related provisions governing voluntary withdrawal. The form identifies the exchange, issuer, security class, and contact details, and bears the exchange signer and date. The filing does not, in the provided text, indicate which specific rule provision box was marked, leaving that element unspecified in this document.
Streamline Health Solutions, Inc. ha presentato un Form 25 notificando la rimozione delle sue azioni ordinarie dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. La comunicazione indica la sede principale e il numero di telefono dell'emittente, cita la dichiarazione di Nasdaq secondo cui ha rispettato le norme applicabili nel depositare il Form 25, ed è firmata da Jennifer Fainer, Analista CDO, in data 2025-08-12.
Streamline Health Solutions, Inc. presentó un Form 25 notificando la eliminación de sus acciones ordinarias de la cotización y/o registro en el Nasdaq Stock Market LLC. La presentación indica la oficina principal y el número de teléfono del emisor, cita la declaración de Nasdaq de que cumplió las normas aplicables al presentar el Form 25, y está firmada por Jennifer Fainer, Analista CDO, con fecha 2025-08-12.
Streamline Health Solutions, Inc.는 보통주를 Nasdaq Stock Market LLC의 상장 및/또는 등록에서 제외한다는 통지를 위해 Form 25를 제출했습니다. 제출 서류에는 발행인의 본사 주소와 전화번호가 기재되어 있고, Form 25를 제출하는 데 있어 적용 규정을 준수했다는 Nasdaq의 진술을 인용하고 있으며, Jennifer Fainer, CDO 분석가의 서명이 있으며 날짜는 2025-08-12입니다.
Streamline Health Solutions, Inc. a déposé un Form 25 notifiant le retrait de ses actions ordinaires de la cotation et/ou de l'enregistrement sur le Nasdaq Stock Market LLC. Le dossier indique le siège social et le numéro de téléphone de l'émetteur, cite la déclaration de Nasdaq selon laquelle elle a respecté les règles applicables lors du dépôt du Form 25, et est signé par Jennifer Fainer, analyste CDO, en date du 2025-08-12.
Streamline Health Solutions, Inc. hat ein Form 25 eingereicht, das die Entfernung seiner Stammaktien von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC anzeigt. Die Einreichung nennt die Hauptniederlassung und Telefonnummer des Emittenten, zitiert die Erklärung der Nasdaq, dass sie die anwendbaren Regeln bei der Einreichung des Form 25 eingehalten hat, und ist von Jennifer Fainer, CDO-Analystin, unterzeichnet, datiert 2025-08-12.